1. Home
  2. SNSE vs FTFT Comparison

SNSE vs FTFT Comparison

Compare SNSE & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • FTFT
  • Stock Information
  • Founded
  • SNSE 2005
  • FTFT N/A
  • Country
  • SNSE United States
  • FTFT United States
  • Employees
  • SNSE N/A
  • FTFT N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • FTFT Business Services
  • Sector
  • SNSE Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • SNSE Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • SNSE 11.2M
  • FTFT 11.0M
  • IPO Year
  • SNSE 2021
  • FTFT N/A
  • Fundamental
  • Price
  • SNSE $11.13
  • FTFT $2.21
  • Analyst Decision
  • SNSE Strong Buy
  • FTFT
  • Analyst Count
  • SNSE 4
  • FTFT 0
  • Target Price
  • SNSE $72.50
  • FTFT N/A
  • AVG Volume (30 Days)
  • SNSE 3.5K
  • FTFT 487.0K
  • Earning Date
  • SNSE 11-13-2025
  • FTFT 11-18-2025
  • Dividend Yield
  • SNSE N/A
  • FTFT N/A
  • EPS Growth
  • SNSE N/A
  • FTFT N/A
  • EPS
  • SNSE N/A
  • FTFT N/A
  • Revenue
  • SNSE N/A
  • FTFT $2,368,206.00
  • Revenue This Year
  • SNSE N/A
  • FTFT N/A
  • Revenue Next Year
  • SNSE N/A
  • FTFT N/A
  • P/E Ratio
  • SNSE N/A
  • FTFT N/A
  • Revenue Growth
  • SNSE N/A
  • FTFT N/A
  • 52 Week Low
  • SNSE $5.00
  • FTFT $1.01
  • 52 Week High
  • SNSE $17.40
  • FTFT $5.70
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 71.14
  • FTFT 50.57
  • Support Level
  • SNSE $9.35
  • FTFT $2.10
  • Resistance Level
  • SNSE $10.00
  • FTFT $2.28
  • Average True Range (ATR)
  • SNSE 0.51
  • FTFT 0.18
  • MACD
  • SNSE 0.09
  • FTFT -0.01
  • Stochastic Oscillator
  • SNSE 94.27
  • FTFT 65.22

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

Share on Social Networks: